BioCentury | Jun 11, 2020
Deals

Cullinan adds first-in-class asset in hot NK cell checkpoint space

...Cullinan Oncology LLC formed its eighth single-asset subsidiary. The anti-MICA mAb was being developed at PDI Therapeutics...
...it assumed control of PDI’s operations, structured the unit as a subsidiary and renamed it Cullinan MICA Inc....
...KLRK1; CD314) - Killer cell lectin-like receptor subfamily K member 1 Lauren Martz, Senior Editor Cullinan Management Inc. Cullinan Mica Inc. Avalon...
BioCentury | Sep 13, 2019
Finance

After single exit, Avalon seeks path forward for build-to-buy assets from GSK deal

...in 2015 to permit more deals, the last start-up the pair announced was cancer play PDI Therapeutics...
BioCentury | Aug 17, 2017
Finance

Built to purpose

...sclerosis (ALS); Silarus Therapeutics Inc. is targeting FAM132b for anemia and iron overload disorders, and PDI Therapeutics...
...OTCQB:MYMX), Epalinges, Switzerland New Enterprise Associates, Menlo Park, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland PDI Therapeutics...
BioCentury | May 30, 2016
Company News

PDI Therapeutics Inc., GlaxoSmithKline cancer news

...Ventures launched cancer immunotherapy company PDI Therapeutics as part of an expanded build-to-buy partnership with GlaxoSmithKline. PDI Therapeutics...
...cells. The newco is housed at Avalon’s COI Pharmaceuticals Inc. (La Jolla, Calif.) incubator. Including PDI Therapeutics...
...collaboration, Avalon would be eligible for $50 million in earn-outs if GSK exercises an option. PDI Therapeutics...
BioCentury | May 21, 2016
Company News

Avalon launches cancer play PDI Therapeutics

...Avalon Ventures launched cancer immunotherapy play PDI Therapeutics Inc. (La Jolla, Calif.) as part of an expanded...
...launched since the partners expanded their deal last fall (see BioCentury, Nov. 16, 2015) . PDI Therapeutics...
..."homegrown" rather than in-licensed. The newco is housed at Avalon's COI Pharmaceuticals Inc. incubator. Including PDI Therapeutics...
Items per page:
1 - 5 of 5
BioCentury | Jun 11, 2020
Deals

Cullinan adds first-in-class asset in hot NK cell checkpoint space

...Cullinan Oncology LLC formed its eighth single-asset subsidiary. The anti-MICA mAb was being developed at PDI Therapeutics...
...it assumed control of PDI’s operations, structured the unit as a subsidiary and renamed it Cullinan MICA Inc....
...KLRK1; CD314) - Killer cell lectin-like receptor subfamily K member 1 Lauren Martz, Senior Editor Cullinan Management Inc. Cullinan Mica Inc. Avalon...
BioCentury | Sep 13, 2019
Finance

After single exit, Avalon seeks path forward for build-to-buy assets from GSK deal

...in 2015 to permit more deals, the last start-up the pair announced was cancer play PDI Therapeutics...
BioCentury | Aug 17, 2017
Finance

Built to purpose

...sclerosis (ALS); Silarus Therapeutics Inc. is targeting FAM132b for anemia and iron overload disorders, and PDI Therapeutics...
...OTCQB:MYMX), Epalinges, Switzerland New Enterprise Associates, Menlo Park, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland PDI Therapeutics...
BioCentury | May 30, 2016
Company News

PDI Therapeutics Inc., GlaxoSmithKline cancer news

...Ventures launched cancer immunotherapy company PDI Therapeutics as part of an expanded build-to-buy partnership with GlaxoSmithKline. PDI Therapeutics...
...cells. The newco is housed at Avalon’s COI Pharmaceuticals Inc. (La Jolla, Calif.) incubator. Including PDI Therapeutics...
...collaboration, Avalon would be eligible for $50 million in earn-outs if GSK exercises an option. PDI Therapeutics...
BioCentury | May 21, 2016
Company News

Avalon launches cancer play PDI Therapeutics

...Avalon Ventures launched cancer immunotherapy play PDI Therapeutics Inc. (La Jolla, Calif.) as part of an expanded...
...launched since the partners expanded their deal last fall (see BioCentury, Nov. 16, 2015) . PDI Therapeutics...
..."homegrown" rather than in-licensed. The newco is housed at Avalon's COI Pharmaceuticals Inc. incubator. Including PDI Therapeutics...
Items per page:
1 - 5 of 5